| . | Triclosan . | No triclosan . | P-value . |
|---|---|---|---|
| N | 184 | 190 | |
| Mean age (year) | 67.6 ± 8.3 | 66.9 ± 8.1 | 0.45 |
| Female sex | 39 (21.1) | 31 (16.3) | 0.23 |
| BMI | 27.6 ± 4.1 | 27.6 ± 4.1 | 0.67 |
| Diabetes | |||
| No | 138 (75.0) | 140 (73.7) | 0.77 |
| Insulin treatment | 22 (11.9) | 21 (11.1) | 0.78 |
| Oral treatment | 20 (10.8) | 22 (11.6) | 0.83 |
| Dietary treatment | 4 (2.2) | 7 (3.7) | 0.38 |
| Smoking | |||
| Never | 70 (38.0) | 74 (38.9) | 0.86 |
| Previous (>1 month ago) | 82 (44.5) | 82 (43.2) | 0.78 |
| On-going | 29 (15.8) | 31 (16.3) | 0.88 |
| Missing | 3 (1.6) | 3 (1.6) | 0.91 |
| Mean EuroSCORE | 4.0 ± 2.0 | 3.7 ± 2.2 | 0.15 |
| Angina type | |||
| Unstable | 88 (47.8) | 95 (50.0) | 0.67 |
| Stable | 90 (48.9) | 93 (48.9) | 0.60 |
| No angina | 6 (3.3) | 2 (1.1) | 0.12 |
| Peripheral artery disease | 16 (8.7) | 16 (8.4) | 0.92 |
| Preoperative medication | |||
| Acetylsalicylic acid | 172 (93.5) | 178 (93.7) | 0.98 |
| Clopidogrel | 70 (38.0) | 72 (37.8) | 0.92 |
| Beta-blocker | 160 (87.0) | 166 (87.4) | 0.97 |
| ACE-inhibitor | 106 (57.6) | 120 (63.1) | 0.24 |
| Corticosteroids | 8 (4.3) | 6 (3.2) | 0.54 |
| Preoperative laboratory analyses | |||
| Haemoglobin (g/l) | 138 ± 13 | 140 ± 14 | 0.33 |
| White blood cell count (×109/l) | 7.6 ± 1.8 | 7.6 ± 1.8 | 0.87 |
| Platelet count (×109/l) | 270 ± 80 | 267 ± 71 | 0.67 |
| Serum creatinine (µmol/l) | 85 ± 23 | 86 ± 22 | 0.48 |
| Plasma-glucose (mmol/l) | 7.1 ± 2.8 | 7.0 ± 2.7 | 0.99 |
| . | Triclosan . | No triclosan . | P-value . |
|---|---|---|---|
| N | 184 | 190 | |
| Mean age (year) | 67.6 ± 8.3 | 66.9 ± 8.1 | 0.45 |
| Female sex | 39 (21.1) | 31 (16.3) | 0.23 |
| BMI | 27.6 ± 4.1 | 27.6 ± 4.1 | 0.67 |
| Diabetes | |||
| No | 138 (75.0) | 140 (73.7) | 0.77 |
| Insulin treatment | 22 (11.9) | 21 (11.1) | 0.78 |
| Oral treatment | 20 (10.8) | 22 (11.6) | 0.83 |
| Dietary treatment | 4 (2.2) | 7 (3.7) | 0.38 |
| Smoking | |||
| Never | 70 (38.0) | 74 (38.9) | 0.86 |
| Previous (>1 month ago) | 82 (44.5) | 82 (43.2) | 0.78 |
| On-going | 29 (15.8) | 31 (16.3) | 0.88 |
| Missing | 3 (1.6) | 3 (1.6) | 0.91 |
| Mean EuroSCORE | 4.0 ± 2.0 | 3.7 ± 2.2 | 0.15 |
| Angina type | |||
| Unstable | 88 (47.8) | 95 (50.0) | 0.67 |
| Stable | 90 (48.9) | 93 (48.9) | 0.60 |
| No angina | 6 (3.3) | 2 (1.1) | 0.12 |
| Peripheral artery disease | 16 (8.7) | 16 (8.4) | 0.92 |
| Preoperative medication | |||
| Acetylsalicylic acid | 172 (93.5) | 178 (93.7) | 0.98 |
| Clopidogrel | 70 (38.0) | 72 (37.8) | 0.92 |
| Beta-blocker | 160 (87.0) | 166 (87.4) | 0.97 |
| ACE-inhibitor | 106 (57.6) | 120 (63.1) | 0.24 |
| Corticosteroids | 8 (4.3) | 6 (3.2) | 0.54 |
| Preoperative laboratory analyses | |||
| Haemoglobin (g/l) | 138 ± 13 | 140 ± 14 | 0.33 |
| White blood cell count (×109/l) | 7.6 ± 1.8 | 7.6 ± 1.8 | 0.87 |
| Platelet count (×109/l) | 270 ± 80 | 267 ± 71 | 0.67 |
| Serum creatinine (µmol/l) | 85 ± 23 | 86 ± 22 | 0.48 |
| Plasma-glucose (mmol/l) | 7.1 ± 2.8 | 7.0 ± 2.7 | 0.99 |
Mean ± standard deviation or number (%).
ACE: angiotensin converting enzyme; BMI: body mass index.
| . | Triclosan . | No triclosan . | P-value . |
|---|---|---|---|
| N | 184 | 190 | |
| Mean age (year) | 67.6 ± 8.3 | 66.9 ± 8.1 | 0.45 |
| Female sex | 39 (21.1) | 31 (16.3) | 0.23 |
| BMI | 27.6 ± 4.1 | 27.6 ± 4.1 | 0.67 |
| Diabetes | |||
| No | 138 (75.0) | 140 (73.7) | 0.77 |
| Insulin treatment | 22 (11.9) | 21 (11.1) | 0.78 |
| Oral treatment | 20 (10.8) | 22 (11.6) | 0.83 |
| Dietary treatment | 4 (2.2) | 7 (3.7) | 0.38 |
| Smoking | |||
| Never | 70 (38.0) | 74 (38.9) | 0.86 |
| Previous (>1 month ago) | 82 (44.5) | 82 (43.2) | 0.78 |
| On-going | 29 (15.8) | 31 (16.3) | 0.88 |
| Missing | 3 (1.6) | 3 (1.6) | 0.91 |
| Mean EuroSCORE | 4.0 ± 2.0 | 3.7 ± 2.2 | 0.15 |
| Angina type | |||
| Unstable | 88 (47.8) | 95 (50.0) | 0.67 |
| Stable | 90 (48.9) | 93 (48.9) | 0.60 |
| No angina | 6 (3.3) | 2 (1.1) | 0.12 |
| Peripheral artery disease | 16 (8.7) | 16 (8.4) | 0.92 |
| Preoperative medication | |||
| Acetylsalicylic acid | 172 (93.5) | 178 (93.7) | 0.98 |
| Clopidogrel | 70 (38.0) | 72 (37.8) | 0.92 |
| Beta-blocker | 160 (87.0) | 166 (87.4) | 0.97 |
| ACE-inhibitor | 106 (57.6) | 120 (63.1) | 0.24 |
| Corticosteroids | 8 (4.3) | 6 (3.2) | 0.54 |
| Preoperative laboratory analyses | |||
| Haemoglobin (g/l) | 138 ± 13 | 140 ± 14 | 0.33 |
| White blood cell count (×109/l) | 7.6 ± 1.8 | 7.6 ± 1.8 | 0.87 |
| Platelet count (×109/l) | 270 ± 80 | 267 ± 71 | 0.67 |
| Serum creatinine (µmol/l) | 85 ± 23 | 86 ± 22 | 0.48 |
| Plasma-glucose (mmol/l) | 7.1 ± 2.8 | 7.0 ± 2.7 | 0.99 |
| . | Triclosan . | No triclosan . | P-value . |
|---|---|---|---|
| N | 184 | 190 | |
| Mean age (year) | 67.6 ± 8.3 | 66.9 ± 8.1 | 0.45 |
| Female sex | 39 (21.1) | 31 (16.3) | 0.23 |
| BMI | 27.6 ± 4.1 | 27.6 ± 4.1 | 0.67 |
| Diabetes | |||
| No | 138 (75.0) | 140 (73.7) | 0.77 |
| Insulin treatment | 22 (11.9) | 21 (11.1) | 0.78 |
| Oral treatment | 20 (10.8) | 22 (11.6) | 0.83 |
| Dietary treatment | 4 (2.2) | 7 (3.7) | 0.38 |
| Smoking | |||
| Never | 70 (38.0) | 74 (38.9) | 0.86 |
| Previous (>1 month ago) | 82 (44.5) | 82 (43.2) | 0.78 |
| On-going | 29 (15.8) | 31 (16.3) | 0.88 |
| Missing | 3 (1.6) | 3 (1.6) | 0.91 |
| Mean EuroSCORE | 4.0 ± 2.0 | 3.7 ± 2.2 | 0.15 |
| Angina type | |||
| Unstable | 88 (47.8) | 95 (50.0) | 0.67 |
| Stable | 90 (48.9) | 93 (48.9) | 0.60 |
| No angina | 6 (3.3) | 2 (1.1) | 0.12 |
| Peripheral artery disease | 16 (8.7) | 16 (8.4) | 0.92 |
| Preoperative medication | |||
| Acetylsalicylic acid | 172 (93.5) | 178 (93.7) | 0.98 |
| Clopidogrel | 70 (38.0) | 72 (37.8) | 0.92 |
| Beta-blocker | 160 (87.0) | 166 (87.4) | 0.97 |
| ACE-inhibitor | 106 (57.6) | 120 (63.1) | 0.24 |
| Corticosteroids | 8 (4.3) | 6 (3.2) | 0.54 |
| Preoperative laboratory analyses | |||
| Haemoglobin (g/l) | 138 ± 13 | 140 ± 14 | 0.33 |
| White blood cell count (×109/l) | 7.6 ± 1.8 | 7.6 ± 1.8 | 0.87 |
| Platelet count (×109/l) | 270 ± 80 | 267 ± 71 | 0.67 |
| Serum creatinine (µmol/l) | 85 ± 23 | 86 ± 22 | 0.48 |
| Plasma-glucose (mmol/l) | 7.1 ± 2.8 | 7.0 ± 2.7 | 0.99 |
Mean ± standard deviation or number (%).
ACE: angiotensin converting enzyme; BMI: body mass index.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
